Report Detail
Global and United States Biopharmaceutical Cmo & Cro Market Insights, Forecast to 2026
- RnM4206933 |
- 15 September, 2020 |
- Global |
- 145 Pages |
- QYResearch |
- Chemical & Material
Biopharmaceutical Cmo & Cro market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Biopharmaceutical Cmo & Cro market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Biopharmaceutical Cmo & Cro market is segmented into
Biologics
Biosimilars
Segment by Application, the Biopharmaceutical Cmo & Cro market is segmented into
Contract Manufacturing
Contract Research
Regional and Country-level Analysis
The Biopharmaceutical Cmo & Cro market is analysed and market size information is provided by regions (countries).
The key regions covered in the Biopharmaceutical Cmo & Cro market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Biopharmaceutical Cmo & Cro Market Share Analysis
Biopharmaceutical Cmo & Cro market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Biopharmaceutical Cmo & Cro business, the date to enter into the Biopharmaceutical Cmo & Cro market, Biopharmaceutical Cmo & Cro product introduction, recent developments, etc.
The major vendors covered:
Lonza
Boehringer Ingelheim GmbH
Rentschler Biotechnologie GmbH
Inno Biologics Sdn Bhd
JRS Pharma (Celonic GmbH)
BIOMEVA GmbH
ProBioGen
FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
TOYOBO CO., LTD
Samsung BioLogics
Patheon
CMC Biologics
Binex Co., Ltd.
AbbVie Inc.
WuXi Biologics.
1 Study Coverage
- 1.1 Biopharmaceutical Cmo & Cro Product Introduction
- 1.2 Market Segments
- 1.3 Key Biopharmaceutical Cmo & Cro Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Biopharmaceutical Cmo & Cro Market Size Growth Rate by Type
- 1.4.2 Biologics
- 1.4.3 Biosimilars
- 1.5 Market by Application
- 1.5.1 Global Biopharmaceutical Cmo & Cro Market Size Growth Rate by Application
- 1.5.2 Contract Manufacturing
- 1.5.3 Contract Research
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Biopharmaceutical Cmo & Cro Market Size, Estimates and Forecasts
- 2.1.1 Global Biopharmaceutical Cmo & Cro Revenue 2015-2026
- 2.1.2 Global Biopharmaceutical Cmo & Cro Sales 2015-2026
- 2.2 Global Biopharmaceutical Cmo & Cro, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.3 Biopharmaceutical Cmo & Cro Historical Market Size by Region (2015-2020)
- 2.3.1 Global Biopharmaceutical Cmo & Cro Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.3.2 Global Biopharmaceutical Cmo & Cro Retrospective Market Scenario in Revenue by Region: 2015-2020
- 2.4 Biopharmaceutical Cmo & Cro Market Estimates and Projections by Region (2021-2026)
- 2.4.1 Global Biopharmaceutical Cmo & Cro Sales Forecast by Region (2021-2026)
- 2.4.2 Global Biopharmaceutical Cmo & Cro Revenue Forecast by Region (2021-2026)
3 Global Biopharmaceutical Cmo & Cro Competitor Landscape by Players
- 3.1 Global Top Biopharmaceutical Cmo & Cro Sales by Manufacturers
- 3.1.1 Global Biopharmaceutical Cmo & Cro Sales by Manufacturers (2015-2020)
- 3.1.2 Global Biopharmaceutical Cmo & Cro Sales Market Share by Manufacturers (2015-2020)
- 3.2 Global Biopharmaceutical Cmo & Cro Manufacturers by Revenue
- 3.2.1 Global Biopharmaceutical Cmo & Cro Revenue by Manufacturers (2015-2020)
- 3.2.2 Global Biopharmaceutical Cmo & Cro Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Biopharmaceutical Cmo & Cro Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Biopharmaceutical Cmo & Cro Revenue in 2019
- 3.2.5 Global Biopharmaceutical Cmo & Cro Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Global Biopharmaceutical Cmo & Cro Price by Manufacturers
- 3.4 Global Biopharmaceutical Cmo & Cro Manufacturing Base Distribution, Product Types
- 3.4.1 Biopharmaceutical Cmo & Cro Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Biopharmaceutical Cmo & Cro Product Type
- 3.4.3 Date of International Manufacturers Enter into Biopharmaceutical Cmo & Cro Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Biopharmaceutical Cmo & Cro Market Size by Type (2015-2020)
- 4.1.1 Global Biopharmaceutical Cmo & Cro Sales by Type (2015-2020)
- 4.1.2 Global Biopharmaceutical Cmo & Cro Revenue by Type (2015-2020)
- 4.1.3 Biopharmaceutical Cmo & Cro Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Biopharmaceutical Cmo & Cro Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Biopharmaceutical Cmo & Cro Sales Forecast by Type (2021-2026)
- 4.2.2 Global Biopharmaceutical Cmo & Cro Revenue Forecast by Type (2021-2026)
- 4.2.3 Biopharmaceutical Cmo & Cro Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Biopharmaceutical Cmo & Cro Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Biopharmaceutical Cmo & Cro Market Size by Application (2015-2020)
- 5.1.1 Global Biopharmaceutical Cmo & Cro Sales by Application (2015-2020)
- 5.1.2 Global Biopharmaceutical Cmo & Cro Revenue by Application (2015-2020)
- 5.1.3 Biopharmaceutical Cmo & Cro Price by Application (2015-2020)
- 5.2 Biopharmaceutical Cmo & Cro Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Biopharmaceutical Cmo & Cro Sales Forecast by Application (2021-2026)
- 5.2.2 Global Biopharmaceutical Cmo & Cro Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Biopharmaceutical Cmo & Cro Price Forecast by Application (2021-2026)
6 United States by Players, Type and Application
- 6.1 United States Biopharmaceutical Cmo & Cro Market Size YoY Growth 2015-2026
- 6.1.1 United States Biopharmaceutical Cmo & Cro Sales YoY Growth 2015-2026
- 6.1.2 United States Biopharmaceutical Cmo & Cro Revenue YoY Growth 2015-2026
- 6.1.3 United States Biopharmaceutical Cmo & Cro Market Share in Global Market 2015-2026
- 6.2 United States Biopharmaceutical Cmo & Cro Market Size by Players (International and Local Players)
- 6.2.1 United States Top Biopharmaceutical Cmo & Cro Players by Sales (2015-2020)
- 6.2.2 United States Top Biopharmaceutical Cmo & Cro Players by Revenue (2015-2020)
- 6.3 United States Biopharmaceutical Cmo & Cro Historic Market Review by Type (2015-2020)
- 6.3.1 United States Biopharmaceutical Cmo & Cro Sales Market Share by Type (2015-2020)
- 6.3.2 United States Biopharmaceutical Cmo & Cro Revenue Market Share by Type (2015-2020)
- 6.3.3 United States Biopharmaceutical Cmo & Cro Price by Type (2015-2020)
- 6.4 United States Biopharmaceutical Cmo & Cro Market Estimates and Forecasts by Type (2021-2026)
- 6.4.1 United States Biopharmaceutical Cmo & Cro Sales Forecast by Type (2021-2026)
- 6.4.2 United States Biopharmaceutical Cmo & Cro Revenue Forecast by Type (2021-2026)
- 6.4.3 United States Biopharmaceutical Cmo & Cro Price Forecast by Type (2021-2026)
- 6.5 United States Biopharmaceutical Cmo & Cro Historic Market Review by Application (2015-2020)
- 6.5.1 United States Biopharmaceutical Cmo & Cro Sales Market Share by Application (2015-2020)
- 6.5.2 United States Biopharmaceutical Cmo & Cro Revenue Market Share by Application (2015-2020)
- 6.5.3 United States Biopharmaceutical Cmo & Cro Price by Application (2015-2020)
- 6.6 United States Biopharmaceutical Cmo & Cro Market Estimates and Forecasts by Application (2021-2026)
- 6.6.1 United States Biopharmaceutical Cmo & Cro Sales Forecast by Application (2021-2026)
- 6.6.2 United States Biopharmaceutical Cmo & Cro Revenue Forecast by Application (2021-2026)
- 6.6.3 United States Biopharmaceutical Cmo & Cro Price Forecast by Application (2021-2026)
7 North America
- 7.1 North America Biopharmaceutical Cmo & Cro Market Size YoY Growth 2015-2026
- 7.2 North America Biopharmaceutical Cmo & Cro Market Facts & Figures by Country
- 7.2.1 North America Biopharmaceutical Cmo & Cro Sales by Country (2015-2020)
- 7.2.2 North America Biopharmaceutical Cmo & Cro Revenue by Country (2015-2020)
- 7.2.3 U.S.
- 7.2.4 Canada
8 Europe
- 8.1 Europe Biopharmaceutical Cmo & Cro Market Size YoY Growth 2015-2026
- 8.2 Europe Biopharmaceutical Cmo & Cro Market Facts & Figures by Country
- 8.2.1 Europe Biopharmaceutical Cmo & Cro Sales by Country
- 8.2.2 Europe Biopharmaceutical Cmo & Cro Revenue by Country
- 8.2.3 Germany
- 8.2.4 France
- 8.2.5 U.K.
- 8.2.6 Italy
- 8.2.7 Russia
9 Asia Pacific
- 9.1 Asia Pacific Biopharmaceutical Cmo & Cro Market Size YoY Growth 2015-2026
- 9.2 Asia Pacific Biopharmaceutical Cmo & Cro Market Facts & Figures by Country
- 9.2.1 Asia Pacific Biopharmaceutical Cmo & Cro Sales by Region (2015-2020)
- 9.2.2 Asia Pacific Biopharmaceutical Cmo & Cro Revenue by Region
- 9.2.3 China
- 9.2.4 Japan
- 9.2.5 South Korea
- 9.2.6 India
- 9.2.7 Australia
- 9.2.8 Taiwan
- 9.2.9 Indonesia
- 9.2.10 Thailand
- 9.2.11 Malaysia
- 9.2.12 Philippines
- 9.2.13 Vietnam
10 Latin America
- 10.1 Latin America Biopharmaceutical Cmo & Cro Market Size YoY Growth 2015-2026
- 10.2 Latin America Biopharmaceutical Cmo & Cro Market Facts & Figures by Country
- 10.2.1 Latin America Biopharmaceutical Cmo & Cro Sales by Country
- 10.2.2 Latin America Biopharmaceutical Cmo & Cro Revenue by Country
- 10.2.3 Mexico
- 10.2.4 Brazil
- 10.2.5 Argentina
11 Middle East and Africa
- 11.1 Middle East and Africa Biopharmaceutical Cmo & Cro Market Size YoY Growth 2015-2026
- 11.2 Middle East and Africa Biopharmaceutical Cmo & Cro Market Facts & Figures by Country
- 11.2.1 Middle East and Africa Biopharmaceutical Cmo & Cro Sales by Country
- 11.2.2 Middle East and Africa Biopharmaceutical Cmo & Cro Revenue by Country
- 11.2.3 Turkey
- 11.2.4 Saudi Arabia
- 11.2.5 U.A.E
12 Company Profiles
- 12.1 Lonza
- 12.1.1 Lonza Corporation Information
- 12.1.2 Lonza Description and Business Overview
- 12.1.3 Lonza Sales, Revenue and Gross Margin (2015-2020)
- 12.1.4 Lonza Biopharmaceutical Cmo & Cro Products Offered
- 12.1.5 Lonza Recent Development
- 12.2 Boehringer Ingelheim GmbH
- 12.2.1 Boehringer Ingelheim GmbH Corporation Information
- 12.2.2 Boehringer Ingelheim GmbH Description and Business Overview
- 12.2.3 Boehringer Ingelheim GmbH Sales, Revenue and Gross Margin (2015-2020)
- 12.2.4 Boehringer Ingelheim GmbH Biopharmaceutical Cmo & Cro Products Offered
- 12.2.5 Boehringer Ingelheim GmbH Recent Development
- 12.3 Rentschler Biotechnologie GmbH
- 12.3.1 Rentschler Biotechnologie GmbH Corporation Information
- 12.3.2 Rentschler Biotechnologie GmbH Description and Business Overview
- 12.3.3 Rentschler Biotechnologie GmbH Sales, Revenue and Gross Margin (2015-2020)
- 12.3.4 Rentschler Biotechnologie GmbH Biopharmaceutical Cmo & Cro Products Offered
- 12.3.5 Rentschler Biotechnologie GmbH Recent Development
- 12.4 Inno Biologics Sdn Bhd
- 12.4.1 Inno Biologics Sdn Bhd Corporation Information
- 12.4.2 Inno Biologics Sdn Bhd Description and Business Overview
- 12.4.3 Inno Biologics Sdn Bhd Sales, Revenue and Gross Margin (2015-2020)
- 12.4.4 Inno Biologics Sdn Bhd Biopharmaceutical Cmo & Cro Products Offered
- 12.4.5 Inno Biologics Sdn Bhd Recent Development
- 12.5 JRS Pharma (Celonic GmbH)
- 12.5.1 JRS Pharma (Celonic GmbH) Corporation Information
- 12.5.2 JRS Pharma (Celonic GmbH) Description and Business Overview
- 12.5.3 JRS Pharma (Celonic GmbH) Sales, Revenue and Gross Margin (2015-2020)
- 12.5.4 JRS Pharma (Celonic GmbH) Biopharmaceutical Cmo & Cro Products Offered
- 12.5.5 JRS Pharma (Celonic GmbH) Recent Development
- 12.6 BIOMEVA GmbH
- 12.6.1 BIOMEVA GmbH Corporation Information
- 12.6.2 BIOMEVA GmbH Description and Business Overview
- 12.6.3 BIOMEVA GmbH Sales, Revenue and Gross Margin (2015-2020)
- 12.6.4 BIOMEVA GmbH Biopharmaceutical Cmo & Cro Products Offered
- 12.6.5 BIOMEVA GmbH Recent Development
- 12.7 ProBioGen
- 12.7.1 ProBioGen Corporation Information
- 12.7.2 ProBioGen Description and Business Overview
- 12.7.3 ProBioGen Sales, Revenue and Gross Margin (2015-2020)
- 12.7.4 ProBioGen Biopharmaceutical Cmo & Cro Products Offered
- 12.7.5 ProBioGen Recent Development
- 12.8 FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
- 12.8.1 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Corporation Information
- 12.8.2 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Description and Business Overview
- 12.8.3 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Sales, Revenue and Gross Margin (2015-2020)
- 12.8.4 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Biopharmaceutical Cmo & Cro Products Offered
- 12.8.5 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Recent Development
- 12.9 TOYOBO CO., LTD
- 12.9.1 TOYOBO CO., LTD Corporation Information
- 12.9.2 TOYOBO CO., LTD Description and Business Overview
- 12.9.3 TOYOBO CO., LTD Sales, Revenue and Gross Margin (2015-2020)
- 12.9.4 TOYOBO CO., LTD Biopharmaceutical Cmo & Cro Products Offered
- 12.9.5 TOYOBO CO., LTD Recent Development
- 12.10 Samsung BioLogics
- 12.10.1 Samsung BioLogics Corporation Information
- 12.10.2 Samsung BioLogics Description and Business Overview
- 12.10.3 Samsung BioLogics Sales, Revenue and Gross Margin (2015-2020)
- 12.10.4 Samsung BioLogics Biopharmaceutical Cmo & Cro Products Offered
- 12.10.5 Samsung BioLogics Recent Development
- 12.11 Lonza
- 12.11.1 Lonza Corporation Information
- 12.11.2 Lonza Description and Business Overview
- 12.11.3 Lonza Sales, Revenue and Gross Margin (2015-2020)
- 12.11.4 Lonza Biopharmaceutical Cmo & Cro Products Offered
- 12.11.5 Lonza Recent Development
- 12.12 CMC Biologics
- 12.12.1 CMC Biologics Corporation Information
- 12.12.2 CMC Biologics Description and Business Overview
- 12.12.3 CMC Biologics Sales, Revenue and Gross Margin (2015-2020)
- 12.12.4 CMC Biologics Products Offered
- 12.12.5 CMC Biologics Recent Development
- 12.13 Binex Co., Ltd.
- 12.13.1 Binex Co., Ltd. Corporation Information
- 12.13.2 Binex Co., Ltd. Description and Business Overview
- 12.13.3 Binex Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)
- 12.13.4 Binex Co., Ltd. Products Offered
- 12.13.5 Binex Co., Ltd. Recent Development
- 12.14 AbbVie Inc.
- 12.14.1 AbbVie Inc. Corporation Information
- 12.14.2 AbbVie Inc. Description and Business Overview
- 12.14.3 AbbVie Inc. Sales, Revenue and Gross Margin (2015-2020)
- 12.14.4 AbbVie Inc. Products Offered
- 12.14.5 AbbVie Inc. Recent Development
- 12.15 WuXi Biologics.
- 12.15.1 WuXi Biologics. Corporation Information
- 12.15.2 WuXi Biologics. Description and Business Overview
- 12.15.3 WuXi Biologics. Sales, Revenue and Gross Margin (2015-2020)
- 12.15.4 WuXi Biologics. Products Offered
- 12.15.5 WuXi Biologics. Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter’s Five Forces Analysis
- 13.5 Primary Interviews with Key Biopharmaceutical Cmo & Cro Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Biopharmaceutical Cmo & Cro Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Biopharmaceutical Cmo & Cro. Industry analysis & Market Report on Biopharmaceutical Cmo & Cro is a syndicated market report, published as Global and United States Biopharmaceutical Cmo & Cro Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of Biopharmaceutical Cmo & Cro market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
